Key result
Elevated IL-6 and hs-CRP detect silent CHD in asymptomatic T2D patients with ~90% sensitivity.
Why the study?
Coronary heart disease in type 2 diabetes mellitus is often asymptomatic, and the role of inflammatory markers IL-6 and hs-CRP in screening for silent disease needed evaluation.
Do elevated levels of IL-6 and hs-CRP predict the presence of silent CHD in asymptomatic patients with T2DM?
Observational (n=169)
Do elevated levels of IL-6 and hs-CRP predict the presence of silent CHD in asymptomatic patients with T2DM?
Answers are grounded in this paper and cite their sources.
Elevated hs-CRP and IL-6 levels are strong predictors of silent coronary heart disease in asymptomatic patients with type 2 diabetes, suggesting their utility in cardiovascular risk stratification.
Background/Aim. A special feature of coronary heart disease (CHD) in patients with type 2 diabetes mellitus (T2DM) is that it is often a symptomatic and occurs as a consequence of cardiovascular autonomic neuropathy. Dysregulation of the autonomic nervous system is associated with elevated values of inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) and interleukin- 6 (IL-6), which accelerate atherosclerosis and the occurrence of cardiovascular complications in patients with T2DM. The aim of the study was to evaluate the importance of determining inflammatory cardiovascular risk markers IL-6 and hs-CRP in screening for the presence of CHD in asymptomatic patients with T2DM. Methods. The study included 169 patients with T2DM without any symptoms and signs of CHD. Ergometric testing proved or ruled out the presence of silent CHD. The levels of hs- CRP and IL-6 were determined by ELISA. Results. IL-6 values were significantly higher in patients with a positive ergometric test (6.83 ? 1.99 pg/mL) compared to patients with a negative ergometric test (3.04 ? 1.39 pg/mL) (p < 0.001). We also found that hs-CRP values in patients with a positive ergometric test were significantly higher compared to patients with a negative ergometric test (6.37 ? 2.25 vs 1.67 ? 1.41 mg/L; p < 0.001). Combinations of IL-6 and hs-CRP with age, HbA1c values, and duration of diabetes, presented through three binary logistic regression models, are significant predictors of silent CHD proven by ergometric testing, ie, with their increase, the probability of a positive ergometric test also increases (p < 0.01). The sensitivity of the associated finding of elevated IL-6 and hs-CRP values in the detection of silent CHD by ergometric testing was 90%, and the specificity was 86%. Conclusion. Hs-CRP and IL-6 are significant predictors of silent CHD, and their determination could be recommended for improving cardiovascular risk stratification in asymptomatic patients with T2DM.
No takes yet. Share an insight, caveat, or question.
Malešević et al. (2021) conducted an observational in Type 2 diabetes mellitus without symptoms of coronary heart disease (n=169). Elevated IL-6 and hs-CRP levels vs. Normal or lower levels of IL-6 and hs-CRP was evaluated on Presence of silent coronary heart disease proven by ergometric testing (p=<0.001). In asymptomatic patients with type 2 diabetes, elevated IL-6 and hs-CRP levels were significant predictors of silent coronary heart disease, detecting it with 90% sensitivity and 86% specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: